000 | 01169 a2200325 4500 | ||
---|---|---|---|
005 | 20250516101536.0 | ||
264 | 0 | _c20121203 | |
008 | 201212s 0 0 eng d | ||
022 | _a1473-5571 | ||
024 | 7 |
_a10.1097/QAD.0b013e3283546623 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCambiano, Valentina | |
245 | 0 | 0 |
_aThe role of individual-based models in understanding the potential impact of antiretroviral therapy for prevention. _h[electronic resource] |
260 |
_bAIDS (London, England) _cJul 2012 |
||
300 |
_a1441-2 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aRNA, Viral _xdrug effects |
700 | 1 | _aPhillips, Andrew N | |
773 | 0 |
_tAIDS (London, England) _gvol. 26 _gno. 11 _gp. 1441-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e3283546623 _zAvailable from publisher's website |
999 |
_c21922322 _d21922322 |